L502-1286 Screening compound: 2-[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophene-2-sulfonamido]-N-(3,4-dimethylphenyl)acetamide

L502-1286 Screening compound: 2-[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophene-2-sulfonamido]-N-(3,4-dimethylphenyl)acetamide
L502-1286 Screening compound: 2-[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophene-2-sulfonamido]-N-(3,4-dimethylphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L502-1286
2-[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophene-2-sulfonamido]-N-(3,4-dimethylphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L502-1286

Molecular Formula

C20H22N4O4S2 (C20 H22 N4 O4 S2)

Compound Name

2-[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophene-2-sulfonamido]-N-(3,4-dimethylphenyl)acetamide

IUPAC name

2-[4-(5-cyclobutyl-124-oxadiazol-3-yl)thiophene-2-sulfonamido]-N-(34-dimethylphenyl)acetamide

SMILES

Cc(cc1)c(C)cc1NC(CNS(c1cc(-c2noc(C3CCC3)n2)cs1)(=O)=O)=O

InChI

InChI=1S/C20H22N4O4S2/c1-12-6-7-16(8-13(12)2)22-17(25)10-21-30(26,27)18-9-15(11-29-18)19-23-20(28-24-19)14-4-3-5-14/h6-9,11,14,21H,3-5,10H2,1-2H3,(H,22,25)

InChI Key

CUKQABACUYNCGZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27458853

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.55

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.301

Distribution Coefficient, logD

4.297

Water Solubility, LogSw

-4.19

Polar Surface Area

98.093

Acid Dissociation Constant (pKa)

9.38

Base Dissociation Constant (pKb)

0.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

L502-1286 in Drug Discovery

Included in Screening Libraries

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L502-1286 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L502-1286?
Check Price and Availability of L502-1286, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L502-1286 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L502-1286
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L502-1286
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L502-1286 available by request